Acelyrin has punted the autoimmune drug prospect izokibep back to Affibody, complet | Acelyrin has punted the autoimmune drug prospect izokibep back to Affibody, completing a retreat from its former ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback